3 unchanged sentences
under the trading symbol “ONOV”.
−Removed: Since October 13, 2022, our common stock has been listed for trading on the New York Stock Exchange (“NYSE”) American under the symbol “CTM”.
+Added: Since October 13, 2022, our common stock has been listed for trading on the NYSE American under the symbol “CTM”.
Holders of Record
9 unchanged sentences
2023 Issuances
+Added: On November 20, 2023, we issued an aggregate of 30,000 shares of common stock to four advisory board members in consideration of services rendered, which we valued at approximately $28,560.
+Added: 2022 Issuances
In the three months ended March 31, 2022, we issued (a) 15,000 shares of common stock in accordance with the Series C Preferred Stock subscription agreements, (b) 15,000 shares of common stock in the exercise of stock options, for which we received $12,000, and (c) 7,500 shares of common stock that vest over twelve months to an advisory board member, which we valued at approximately $30,000.
27 unchanged sentences
On February 13, 2023, the Company entered into a series of transactions with Crom to pay off the total amount currently owed under the terms of the convertible promissory note.
−Removed: Refer to subsequent events in Note 16 under Part II, Item 8 on this Annual Report on Form 10-K for details.
2021 Issuances
1 unchanged sentence
On September 16, 2021, September 23, 2021, October 20, 2021, November 18, 2021, November 23, 2021, and December 9, 2021, we issued a total of 620,000 shares of Series C Preferred Stock, for proceeds of $620,000, to various outside investors to finance the Company’s operations, acquisitions, and development.
−Removed: On April 29, 2021 and June 15, 2021, we issued 1,114,023 shares of common stock in connection with the acquisition of MFSI, valued at approximately $1,800,000.
−Removed: On August 6, 2021, we issued 500,000 shares of common stock in connection with the acquisition of Merrison, valued at approximately $1,700,000.
−Removed: On August 25, 2021, we issued 2,600,000 shares of common stock in connection with the acquisition of SSI, valued at approximately $5,200,000.
+Added: On April 29, 2021 and June 15, 2021, we issued 1,114,023 shares of common stock in connection with the acquisition of Mainnerve Federal Services, Inc., valued at approximately $1,800,000.
+Added: On August 6, 2021, we issued 500,000 shares of common stock in connection with the acquisition of Merrison Technologies, LLC, valued at approximately $1,700,000.
+Added: On August 25, 2021, we issued 2,600,000 shares of common stock in connection with the acquisition of Specialty Systems, Inc.
+Added: (“SSI”), valued at approximately $5,200,000.
On September 16, 2021, September 23, 2021, October 20, 2021, November 18, 2021, November 23, 2021, and December 9, 2021, we issued a total of 62,000 shares of common stock to the holders of the Series C Preferred Stock in accordance with the subscription agreements.
17 unchanged sentences
Unsecured Note Payable
−Removed: On August 12, 2021, we issued the Kaunitz Note, in the principal amount of $400,000 that has a maturity date of December 31, 2024 and bears interest at a rate of five percent (5%).
+Added: On August 12, 2021, we issued a note to Emil Kaunitz in the principal amount of $400,000 that has a maturity date of December 31, 2024 and bears interest at a rate of five percent (5%).
+Added: The maturity date and other terms of this note were subsequently amended.
+Added: See subsequent events under Note 16 Part II Item 8.
+Added: Financial Statements on this Annual Report on Form 10-K.
Convertible Note Payable
−Removed: On February 1, 2021, the First Buckhout Charitable Remainder Trust (“BCR”) Trust Note and the Second BCR Trust Note, which were issued in connection with acquisition of Corvus Consulting, Inc.
−Removed: (“Corvus”) were combined into one new note in the principal amount of $4,279,617 referred to as the Third BCR Trust Note, that has a maturity date of February 1, 2024.
+Added: On February 1, 2021, the First Buckhout Charitable Remainder Trust (“BCR”) Trust Note and the Second BCR Trust Note, which were issued in connection with acquisition of Corvus Consulting, LLC were combined into one new note in the principal amount of $4,279,617 referred to as the Third BCR Trust Note, that has a maturity date of February 1, 2024.
The interest rate remains at five percent (5%) per annum and required monthly principal payments of $10,000.
The Third BCR Trust Note is convertible into common stock of the Company at $0.26 per share.
−Removed: 2020 Issuances
−Removed: On May 2, 2020, we issued 550,000 shares of common stock, which we valued at approximately $110,000, to a director in partial satisfaction for the repayment of a director’s notes plus accrued interest.
−Removed: On June 12, 2020, we issued 110,000 shares of common stock at $1.00 per share to two existing stockholders of the Company, which we valued at $110,000.
−Removed: On August 10, 2020, we issued 6,732 shares of common stock at $1.49 per share to the former chief executive officer of Corvus, which we valued at approximately $10,000.
−Removed: Stock Options
−Removed: On January 21, 2020, we granted options to two advisory board members to purchase 100,000 shares of common stock at an exercise price of $0.80 per share for services rendered.
−Removed: On February 1, 2020, we granted options to an advisory board member and employees to purchase 1,209,375 shares of common stock at an exercise price of $0.80 per share.
−Removed: Convertible Note Payable
−Removed: On March 31, 2020, in connection with our acquisition of Corvus, we issued the Second BCR Trust Note in the principal amount of $670,138 that had a maturity date of November 21, 2022.
−Removed: The Second BCR Trust Note had an interest rate of five percent (5%) and is convertible into common stock of the Company at $0.26 per share.
+Added: The maturity date and other terms of this note were subsequently amended.
+Added: See subsequent events under Note 16 Part II Item 8.
+Added: Financial Statements on this Annual Report on Form 10-K.
Use of Proceeds
10 unchanged sentences
There has been no material change in the planned use of proceeds from our Public Offering as described in our final prospectus dated October 12, 2022 and filed with the SEC on October 14, 2022 pursuant to Rule 424(b)(4) of the Securities Act.
−Removed: As of the date of this Annual Report on Form 10-K, we cannot predict with certainty all of the particular uses for the net proceeds, or the amounts that we will actually spend on the uses set forth in the prospectus.
+Added: As planned, we paid $500,000 to satisfy, in part, principal remaining under the amended and restated convertible promissory note payable to the Buckhout Charitable Remainder Trust, funded, in part, the acquisition of GTMR, and have used remaining funds for working capital and general corporate purposes.
Issuer Purchases of Equity Securities
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.